Who is backing RPM technology?

This blog post has been written by the person who has mapped the Remote Patient Monitoring market in a clean and beautiful presentation

The Remote Patient Monitoring sector is experiencing unprecedented investment momentum, with venture capital firms and corporate giants pouring billions into AI-driven platforms, wearable technology, and chronic disease management solutions.

Major players like Sands Capital, Menlo Ventures, and corporate investors including Philips and Medtronic are actively reshaping the healthcare landscape through strategic RPM investments. Companies like Biofourmis have raised massive rounds exceeding $460 million, while emerging players continue to attract significant Series B and C funding rounds.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

Which venture capital firms and corporate investors are leading RPM funding rounds?

Sands Capital leads the institutional investor pack, having participated in HealthSnap's $25 million Series B round alongside Comcast Ventures.

Menlo Ventures took the lead investor role in Solace's substantial $60 million Series B round, joined by SignalFire and Inspired Capital. This round valued Solace at $300 million, demonstrating strong investor confidence in patient advocacy platforms integrated with Medicare coverage.

Integrity Growth Partners (IGP) spearheaded CoachCare's $48 million investment, focusing specifically on virtual care management platforms. Nordic Capital made strategic moves by acquiring Arcadia Solutions, a healthcare analytics company, to enhance AI-driven healthcare outcomes.

Corporate investors are equally active, with Philips expanding their RPM solutions and developing AI-powered monitoring platforms. Medtronic continues innovating in cardiac care RPM devices while exploring acquisition opportunities to expand their digital health offerings.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

What specific technologies and solutions do recently funded RPM startups provide?

Biofourmis, with $463.6 million in funding, develops sophisticated AI-driven platforms for personalized health monitoring, representing the largest single investment in the RPM space.

Forward Health secured $325 million to build intelligent clinics featuring remote biometrics monitoring and predictive risk scoring systems. Their approach combines physical clinic infrastructure with advanced digital monitoring capabilities.

HealthSnap's $25 million Series B funding supports their comprehensive RPM and chronic care management solutions, specifically targeting diabetes, hypertension, and cardiovascular disease monitoring. Sibel Health's $30 million Series C round advances their wearable-based RPM platform that provides continuous patient monitoring through advanced sensor technology.

CoachCare's $48 million investment enhances their virtual care management platform, which combines patient coaching with remote monitoring data to improve chronic disease outcomes. Solace's $60 million round expands their patient advocacy services that help navigate complex healthcare systems while incorporating remote monitoring data.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

How much funding did major RPM companies receive in 2024-2025, and from which specific investors?

The funding landscape shows significant variation in round sizes and investor participation across different RPM subsectors.

What are the typical investment terms and conditions for RPM funding rounds?

RPM investment terms vary significantly based on company stage, with Series A rounds typically involving 15-25% equity stakes for $10-30 million investments.

Series B rounds show higher valuations, exemplified by Solace's $300 million valuation during their $60 million raise, suggesting investors acquired approximately 20% equity. Pre-money valuations for Series B companies typically range from $150-400 million depending on revenue traction and market positioning.

Growth-stage rounds like CoachCare's $48 million investment often involve lower equity percentages but include board seats and liquidation preferences. Corporate strategic investors like Philips and Comcast Ventures frequently negotiate commercial partnerships alongside their equity investments.

Valuation multiples in RPM reflect the sector's growth potential, with revenue multiples ranging from 8-15x for profitable companies and higher multiples for AI-focused platforms showing rapid user acquisition. Liquidation preferences typically favor investors with 1-2x non-participating preferred returns.

Which geographic regions attract the most RPM investment capital?

North America dominates RPM investment activity, capturing approximately 70% of global funding due to favorable reimbursement policies and large addressable markets.

The United States leads with companies like Forward Health ($325M), Solace ($60M), and HealthSnap ($25M) securing major rounds. Supportive Medicare and Medicaid reimbursement structures for RPM services create sustainable revenue models that attract investor confidence.

Asia-Pacific emerges as the second-largest region, with Singapore-based Biofourmis raising $463.6 million, demonstrating the region's growing innovation capabilities. Countries like South Korea, Japan, and Australia show increasing investment activity driven by aging populations and government digital health initiatives.

Europe attracts strategic investments from corporate players like Philips, who actively invest in and acquire European RPM startups. The region benefits from structured healthcare systems and GDPR-compliant data frameworks that appeal to institutional investors focused on scalable, regulation-friendly solutions.

How are major technology and healthcare corporations backing RPM companies?

Philips leads corporate investment activity through both direct investments and strategic acquisitions, focusing on AI-powered RPM solutions that integrate with their existing medical device portfolio.

Medtronic provides RPM devices particularly in cardiac care while continuously exploring acquisition opportunities to expand their digital health capabilities. Their strategy involves partnering with software companies to create comprehensive monitoring ecosystems.

Comcast Ventures participated in HealthSnap's Series B round, leveraging their connectivity infrastructure to support RPM data transmission and storage requirements. Their investment aligns with broader telecommunications industry trends toward healthcare technology integration.

Amazon, Apple, and Google maintain indirect involvement through their healthcare platforms and wearable device ecosystems, though direct RPM startup investments remain limited. These companies focus on building foundational infrastructure that RPM companies can leverage rather than direct competitive investments.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

If you want to build or invest on this market, you can download our latest market pitch deck here

What breakthrough innovations and research developments are attracting investor funding?

AI integration represents the primary innovation driver, with companies developing predictive analytics that identify health deterioration before clinical symptoms appear.

Advanced wearable technology attracts significant investment, particularly platforms that monitor multiple biomarkers simultaneously through non-invasive sensors. Sibel Health's $30 million Series C specifically targets wearable-based continuous monitoring capabilities.

Behavioral health monitoring expansion draws investor attention as companies integrate mental health assessments with traditional physical health metrics. This convergence creates comprehensive patient profiles that enable more effective intervention strategies.

Machine learning algorithms for early detection and intervention represent another key innovation area, with investors funding platforms that can process vast amounts of patient data to identify patterns and predict health events. These capabilities transform RPM from reactive monitoring to proactive health management.

What were the total global funding amounts for RPM companies in 2024 and 2025?

The global RPM market reached approximately $5.1 billion in total value during 2024, with investment funding representing a significant portion of this growth.

Based on disclosed rounds, major RPM companies raised over $950 million in 2024-2025, led by Biofourmis ($463.6M), Forward Health ($325M), and other significant rounds. However, this represents only publicly disclosed funding, with total investment likely exceeding $2 billion when including undisclosed rounds and smaller investments.

The AI-focused segment of RPM is projected to reach $8.4 billion by 2030, growing at a 27.5% CAGR, indicating sustained investor confidence and continued funding availability. Market projections suggest the overall RPM market will surpass $10 billion by 2030.

Early 2025 data shows continued momentum with companies like Sibel Health securing substantial Series C funding, suggesting annual funding levels may match or exceed 2024 totals despite broader venture capital market constraints.

What investment trends are emerging in AI integration, wearables, and chronic disease monitoring?

AI-powered solutions dominate current investment trends, with investors prioritizing platforms that combine machine learning with clinical expertise to deliver predictive insights.

Wearable technology investments focus on multi-parameter monitoring devices that can track cardiovascular, respiratory, and metabolic indicators simultaneously. Investors favor platforms that integrate seamlessly with existing healthcare workflows rather than standalone monitoring solutions.

Chronic disease management attracts the largest funding amounts, particularly platforms addressing diabetes, heart disease, and COPD. Investors recognize the significant cost savings potential when RPM prevents emergency interventions and hospital readmissions.

Integration with telehealth platforms represents an emerging trend, with investors backing companies that combine remote monitoring with virtual care delivery. This convergence creates comprehensive digital health ecosystems that can replace traditional in-person care for many conditions.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

If you need to-the-point data on this market, you can download our latest market pitch deck here

Which RPM companies are positioned for large funding rounds or IPOs in 2026?

Biofourmis stands as the leading IPO candidate given their $463.6 million funding and established market presence across multiple countries.

Forward Health's $325 million round and intelligent clinic model position them for potential public offering consideration, particularly if they demonstrate scalable revenue growth and successful market expansion. Their combination of physical and digital infrastructure appeals to growth-stage investors.

Solace's $300 million valuation and Medicare integration create strong IPO fundamentals, especially as their patient advocacy platform scales across different healthcare systems. Companies with proven reimbursement models typically attract public market investor confidence.

Several indicators support these expectations: increasing revenue multiples, recruitment of executives with public company experience, and secondary market trading activity that suggests pre-IPO positioning. The growing RPM market size and mainstream healthcare adoption create favorable conditions for public offerings.

What accelerators, incubators, and government grants support RPM innovation?

Federal grant programs provide substantial support for RPM innovation, particularly the Distance Learning and Telemedicine (DLT) program that funds rural healthcare technology deployment.

SAMHSA grants specifically target mental health RPM applications, supporting companies that integrate behavioral health monitoring with traditional medical metrics. These grants often range from $500,000 to $2 million for pilot programs and validation studies.

Healthcare-focused accelerators continue nurturing RPM startups through specialized programs that provide industry connections, regulatory guidance, and access to clinical trial partnerships. These programs typically offer $100,000-500,000 in initial funding plus extensive mentorship networks.

State-level innovation programs provide additional funding opportunities, particularly in states with large healthcare sectors like California, Massachusetts, and Texas. These programs often focus on local job creation and healthcare cost reduction through technology innovation.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

What signals indicate RPM market maturation and growth phase evolution?

Increased adoption rates among healthcare providers signal market maturation, with more hospitals and clinics integrating RPM into standard care protocols rather than treating it as experimental technology.

Regulatory support evolution demonstrates market maturity, as policies adapt to support RPM reimbursement and integration with existing healthcare systems. Medicare and Medicaid coverage expansion for RPM services creates sustainable revenue models that attract institutional investment.

Technological advancement indicators include the shift from basic monitoring to AI-powered predictive analytics, suggesting the market has moved beyond simple data collection to sophisticated health management platforms. This evolution attracts higher valuations and more strategic investor interest.

Consolidation activity increases as mid-stage companies seek scale advantages and larger players acquire innovative startups to expand their capabilities. This M&A activity typically indicates market maturation and the emergence of clear industry leaders.

Conclusion

Sources

1. Nordic Capital Acquires Healthcare Analytics Company Arcadia
2. CoachCare Announces $48 Million Investment Led By Integrity Growth Partners
3. HealthSnap Secures $25M to Expand Remote Patient Monitoring Solutions
4. Medicare Coverage Fuels Solace's $60 Million Series B
5. RPM Market Leaders: A Spotlight on Philips and Medtronic
6. Top 66 Remote Patient Monitoring startups
7. CoachCare Secures $48 Million Investment to Accelerate Growth
8. Sibel Health Rakes In $30M for Its Wearable-Based RPM Platform
9. Top RPM Vendors 2025: Driving Remote Patient Monitoring Solutions
10. Top 100 Remote Patient Monitoring Companies Worldwide
11. Remote Patient Monitoring Statistics
12. Remote Patient Monitoring System Market Analysis
13. Global Remote Patient Monitoring Market & Trend
14. AI in Remote Patient Monitoring Market Growth and Drivers
15. RPM Funding: What Grants Are Available To Fund RPM?